Home Page News Statistics API Review API Price Formulation Market report Im&Ex report Free Information All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Industry
Potential coronavirus drug approved for marketing2020-02-21
Pharmaceutical enterprises resumed production2020-02-12
China Coronavirus outbreak may influence Indian drug manufacturers2020-02-05
Bidding result of 2nd batch quantity-ensured procurement including 32 drugs2020-01-21
India started anti-dumping investigation for Chinas Ciprofloxacin2020-01-20
Jiangsu Xiangshui closed some chemical factories2020-01-16
Export license cancelled for Vitamin C2020-01-06
China to realize park industrialization of API production2020-01-05
Quantity-ensured procurement to cover 33 drugs2020-01-02
India approved 4 APIs parks2019-12-30
China to adjust import tariffs on some APIs2019-12-23
Quantity-ensured procurement to cover 35 drugs2019-12-03
More 70 drugs included in China national medical insurance catalog2019-12-03
China extended antidumping review to Indian GCLE2019-11-25
China stop antidumping duty for Pyridine2019-11-22
China encouraged & phase-out category for pharmaceutical projects2019-11-08
China to ease burden of diabetes & hypertension2019-10-10
Medical insurance covers diabetes hypertension outpatient2019-09-17
Quantity-ensured procurement to cover whole China2019-09-04
3rd batch encouraged R&D list of childrens drugs2019-09-04
Insurance to cover online medical services2019-09-04
148 drugs newly covered by Chinas basic medical insurance2019-08-23
One Indian Pharma to scale up business in China2019-08-15
Sino-Indian pharmaceutical companies accelerate cooperation2019-08-05
China started anti-dumping investigation for 2 chemcials2019-07-30
India resumed anti-dumping duty for Chinas Paracetamol2019-07-15
Indian wants reducing reliance on China APIs2019-07-10
First batch of national key monitoring drug list issued2019-07-09
Hebei started quantity-ensured procurement 2019-07-09
Letter of Apology2019-07-09
New vaccine administration law issued2019-07-04
First Batch Suggestion List of Encouraged Generic Drugs2019-06-25
共1471个 页次:2/46页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463